These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1686564)

  • 1. [Effects of buspirone and buspirone-like 1-A-agonists of serotonin on the level of systemic blood pressure].
    Komissarov IV; Mamonov AV; Filippov IT
    Biull Eksp Biol Med; 1991 Jul; 112(7):62-4. PubMed ID: 1686564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the alpha 2-adrenoceptor blocking properties of buspirone and ipsapirone in healthy subjects. Relationship with the plasma concentration of the common metabolite 1-(2-pyrimidinyl)-piperazine.
    Berlin I; Chalon S; Payan C; Schöllnhammer G; Cesselin F; Varoquaux O; Puech AJ
    Br J Clin Pharmacol; 1995 Mar; 39(3):243-9. PubMed ID: 7619663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The different mechanism of the inhibition by buspirone and its camphorimide analogs of 5-HT3-serotoninergic effects].
    Kharin NA; Abramets II; Komissarov IV; Samoĭlovich IM
    Biull Eksp Biol Med; 1993 Aug; 116(8):167-9. PubMed ID: 7903873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alpha 2-adrenoceptor antagonist activity of ipsapirone and gepirone is mediated by their common metabolite 1-(2-pyrimidinyl)-piperazine (PmP).
    Bianchi G; Caccia S; Della Vedova F; Garattini S
    Eur J Pharmacol; 1988 Jul; 151(3):365-71. PubMed ID: 2905658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The GABA-ergic component of the anxiolytic action of 1-(2-pyrimidinyl)-piperazine derivatives].
    Abramets II; Talalaenko AN; Stakhovskiĭ IuV
    Eksp Klin Farmakol; 1992; 55(6):5-7. PubMed ID: 1363956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The pharmacology of 1-(2-pyrimidinyl)piperazine, a metabolite of buspirone].
    Komissarov IV; Dulenko VI; Kharin NA; Tolkunov SV; Talalaenko AN
    Farmakol Toksikol; 1989; 52(2):27-30. PubMed ID: 2568272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effect of buspirone and 1-(2-pyrimidinyl)-piperazine on cerebral glucose utilization in the rat.
    Grasby P; Sharp T; Moorman J; Grahame-Smith D
    Eur J Pharmacol; 1993 Jan; 230(1):41-6. PubMed ID: 8094054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of buspirone and its metabolite, 1-(2-pyrimidinyl)piperazine, on brain monoamines and their metabolites in rats.
    Fuller RW; Perry KW
    J Pharmacol Exp Ther; 1989 Jan; 248(1):50-6. PubMed ID: 2521515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The serotonin- and dopaminergic mechanisms in the action of 1-pyrimidinyl piperazine derivatives].
    Abramets II; Obraztsova OG; Samoĭlovich IM; Kharin NA
    Eksp Klin Farmakol; 1992; 55(3):8-11. PubMed ID: 1360856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative behavioural profiles of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in the murine elevated plus-maze.
    Cao BJ; Rodgers RJ
    Neuropharmacology; 1997 Aug; 36(8):1089-97. PubMed ID: 9294974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic-pharmacodynamic modeling of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in rats.
    Zuideveld KP; Rusiç-Pavletiç J; Maas HJ; Peletier LA; Van der Graaf PH; Danhof M
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1130-7. PubMed ID: 12438536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of clonidine antinociception by buspirone and 1-(2-pyrimidinyl)-piperazine.
    Cao BJ; Li WP
    Eur J Pharmacol; 1994 Jun; 259(1):75-8. PubMed ID: 7957598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased rates of punished responding produced by buspirone-like compounds in rats.
    Sanger DJ
    J Pharmacol Exp Ther; 1992 May; 261(2):513-7. PubMed ID: 1349641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone.
    Moser PC
    Psychopharmacology (Berl); 1989; 99(1):48-53. PubMed ID: 2528779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiolytic 5-hydroxytryptamine1A agonists suppress firing activity of dorsal hippocampus CA1 pyramidal neurons through a postsynaptic mechanism: single-unit study in unanesthetized, unrestrained rats.
    Tada K; Kasamo K; Ueda N; Suzuki T; Kojima T; Ishikawa K
    J Pharmacol Exp Ther; 1999 Feb; 288(2):843-8. PubMed ID: 9918598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buspirone and 1-(2-pyrimidinyl)-piperazine attenuate xylazine-induced antinociception in the mouse.
    Cao BJ; Li WP
    J Pharm Pharmacol; 1994 Nov; 46(11):931-2. PubMed ID: 7897604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The correlation of the serotonin-positive and anxiolytic activities of nonbenzodiazepine substances].
    Abramets II; Dolzhenko AT; Komissarov IV; Samoĭlovich IM; Talalaenko AN; Kharin NA
    Farmakol Toksikol; 1990; 53(5):13-6. PubMed ID: 1979279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An analysis of the hypothermic action of 8-hydroxy-2-(di-N-propylamino)tetralin, 1-(2-pyrimidinyl)piperazine and its derivatives].
    Komissarov IV; Dolzhenko AT; Obraztsova OG; Zin'kovskaia LIa
    Biull Eksp Biol Med; 1990 Mar; 109(3):275-7. PubMed ID: 2142007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The possible neurochemical mechanisms of the neuroleptic action of buspirone-like serotonin agonists].
    Kharin NA; Dolzhenko AT; Titievskiĭ AV; Naletov SV
    Eksp Klin Farmakol; 1993; 56(4):12-4. PubMed ID: 8106056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.